Atlas Trials

Muscarinic Receptor Antagonists as a Therapy for Diabetic Neuropathy

Clinical trial NCT03050827 · COMPLETED

Trial details

NCT number
NCT03050827
Sponsor
Eastern Virginia Medical School
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetic; Neuropathic, Polyneuropathy (Manifestation)
Start date
2014-05-01
Primary completion
2017-08-17
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.